// App-Quantinova.ai

7543 : Subsequent primary malignancies (SPMs) after diffuse large B-cell lymphoma (DLBCL) in the modern treatment era.

Researchers

Presenter

  • Theresa H.M. Keegan

Principal Investigators

  • Christina A Clarke

  • Aaron Seth Rosenberg

  • Ranjana H. Advani

  • Brian Andrew Jonas

  • Christopher Flowers

  • Li Tao

Medical Centers

  • Center for Oncology Hematology Outcomes Research and Training (COHORT), UC Davis Comprehensive Cancer Center, Sacramento, CA

  • Cancer Prevention Institute of California, Fremont, CA

  • UC Davis Cancer Center, Sacramento, CA

  • Stanford School of Medicine, Stanford, CA

  • UC Davis Comprehensive Cancer Center, Sacramento, CA

  • Winship Cancer Institute of Emory University, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Diffuse large B-cell lymphoma

  • Solid malignancies

  • Systemic inflammatory response syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved